Hellenic Institute For The Study Of Sepsis

This study tests if the drug anakinra can help people with long COVID who have ongoing breathing issues and signs of an overactive immune system. About 182 adults will receive either anakinra or a placebo for up to 8 weeks. The goal is to see if the drug improves lung function, r…

This study tests whether giving the antibiotic clarithromycin early, guided by a blood test (suPAR), can prevent pneumonia from worsening into sepsis. About 330 adults with community-acquired pneumonia will receive either clarithromycin or a placebo. The goal is to see if this ap…

This study follows 650 adults who had pneumonia (including COVID-19) to see how the infection might lead to heart disease later. Researchers will collect blood samples, run heart and lung tests, and track heart attacks, strokes, and other events over three years. No new treatment…

This study follows 345 adults to learn how COVID-19 may cause lasting damage to the lungs, heart, and kidneys. Researchers will compare people who had COVID-19 with those who did not, using blood tests, breathing tests, and heart scans. The goal is to find early warning signs and…